Neural Development

Neural development describes the growth and development of the nervous system starting from embryogenesis and continuing throughout life.

Neural Development Products Targets

Cat.No. Product Name Information/Activity
BCC7168 ALX 5407 hydrochloride Selective non-transportable GlyT1 inhibitor
BCC7069 N-Arachidonylglycine 179113-91-8
BCC7677 LY 2365109 hydrochloride 868265-28-5
BCC7845 Org 24598 lithium salt 722456-08-8
BCC6288 Org 25543 hydrochloride Potent and selective GlyT2 inhibitor
BCN2744 Sarcosine Sarcosine is a glycine transporter type 1 (GlyT) inhibitor and an N-methyl-D-aspartate (NMDA) receptor co-agonist at the glycine binding site.
BCC2291 Cilostazol Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM.
BCC6271 Decynium 22 977-96-8
BCC6660 Dilazep dihydrochloride Dilazep dihydrochloride is an inhibitor of adenosine uptake. Dilazep dihydrochloride has cerebral and coronary vasodilating action through enhancement of effect of adenosine. Dilazep dihydrochloride also inhibits the ischemic damage, platelet aggregation, and membrane transport of nucleosides.
BCC1312 5-Iodotubercidin 5-Iodotubercidin (NSC 113939), an ATP mimetic, is a potent adenosine kinase inhibitor with an IC50 of 26 nM. 5-Iodotubercidin (NSC 113939) initiates glycogen synthesis in isolated hepatocytes by causing inactivation of phosphorylase and activation of glycogen synthase. 5-Iodotubercidin (NSC 113939) also inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC and Haspin.